{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:04:12Z","timestamp":1784736252416,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Otorrinolaringologica (English Edition)"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.otoeng.2026.512335","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:20:11Z","timestamp":1772900411000},"page":"512335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mepolizumab in chronic rhinosinusitis with severe nasal polyposis: Real-life Spanish cohort study"],"prefix":"10.1016","volume":"77","author":[{"given":"Paula","family":"Cruz-Toro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Golet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Llansana-Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Clemente-Agodino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pardo-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Gonzalez-Lluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Gonzalez-Compta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.otoeng.2026.512335_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18176\/jiaci.0910","article-title":"POLINA groupSpanish consensus on the management of chronic rhinosinusitis with nasal polyps (POLIposis NAsal\/POLINA 2.0)","volume":"33","author":"Alobid","year":"2023","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"Suppl S29","key":"10.1016\/j.otoeng.2026.512335_bib0010","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"9","key":"10.1016\/j.otoeng.2026.512335_bib0015","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2014an underestimated disease. A GA2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.otoeng.2026.512335_bib0020","first-page":"343","article-title":"The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.otoeng.2026.512335_bib0025","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otoeng.2026.512335_bib0030","first-page":"194","article-title":"EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"issue":"3","key":"10.1016\/j.otoeng.2026.512335_bib0035","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.otoeng.2026.512335_bib0040","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/14740338.2019.1675634","article-title":"A drug safety review of treating eosinophilic asthma with monoclonal antibodies","volume":"18","author":"Mitchell","year":"2019","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"10.1016\/j.otoeng.2026.512335_bib0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.otoeng.2026.512335_bib0050","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","article-title":"Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otoeng.2026.512335_bib0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biomedicines11020485","article-title":"Real-life effectiveness of mepolizumab in refractory chronic rhinosinusitis with nasal polyps","volume":"11","author":"Dom\u00ednguez-Sosa","year":"2023","journal-title":"Biomedicines."},{"issue":"8","key":"10.1016\/j.otoeng.2026.512335_bib0060","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/jpm12081304","article-title":"Mepolizumab improves outcomes of chronic rhinosinusitis with nasal polyps in severe asthmatic patients: a multicentric real-life study","volume":"12","author":"Gallo","year":"2022","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.otoeng.2026.512335_bib0065","first-page":"312","article-title":"Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative","volume":"61","author":"Philpott","year":"2023","journal-title":"Rhinology"},{"issue":"2","key":"10.1016\/j.otoeng.2026.512335_bib0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14639\/0392-100X-N0364","article-title":"Prognostic value of the Sinonasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis","volume":"40","author":"Gallo","year":"2020","journal-title":"Acta Otorhinolaryngol Ital."},{"issue":"10","key":"10.1016\/j.otoeng.2026.512335_bib0075","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1097\/01.mlg.0000234915.51189.cb","article-title":"Clinical significance of results from olfactory testing","volume":"116","author":"Gudziol","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otoeng.2026.512335_bib0080","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211009398","article-title":"Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study","volume":"15","author":"Detoraki","year":"2021","journal-title":"Ther Adv Respir Dis"},{"issue":"4","key":"10.1016\/j.otoeng.2026.512335_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2024.104329","article-title":"Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: real life data in a tertiary care","volume":"45","author":"Galletti","year":"2024","journal-title":"Am J Otolaryngol"},{"issue":"14","key":"10.1016\/j.otoeng.2026.512335_bib0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/imt-2023-0026","article-title":"Mepolizumab in chronic rhinosinusitis with nasal polyposis","volume":"15","author":"Liu","year":"2023","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.otoeng.2026.512335_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2024.104597","article-title":"Mepolizumab in chronic rhinosinusitis with nasal polyps: real life data in a multicentric Sicilian experience","volume":"46","author":"Galletti","year":"2025","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.otoeng.2026.512335_bib0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00405-024-09027-8","article-title":"Effects of mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study","volume":"282","author":"Galletti","year":"2025","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"33","key":"10.1016\/j.otoeng.2026.512335_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin22.483","article-title":"Position paper on olfactory dysfunction: 2023","volume":"61","author":"Whitcroft","year":"2023","journal-title":"Rhinology"}],"container-title":["Acta Otorrinolaringologica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573526000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573526000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:42:17Z","timestamp":1784734937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173573526000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2173573526000207"],"URL":"https:\/\/doi.org\/10.1016\/j.otoeng.2026.512335","relation":{},"ISSN":["2173-5735"],"issn-type":[{"value":"2173-5735","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab in chronic rhinosinusitis with severe nasal polyposis: Real-life Spanish cohort study","name":"articletitle","label":"Article Title"},{"value":"Acta Otorrinolaringologica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otoeng.2026.512335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Otorrinolaringolog\u00eda y Cirug\u00eda de Cabeza y Cuello.","name":"copyright","label":"Copyright"}],"article-number":"512335"}}